Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
Michael A Singer,1 Michael E Jansen,2 Lyndon Tyler,2 Paul Woods,1 Faisal Ansari,2 Udit Jain,2 Joshua Singer,1 Darren Bell,1 Chelsey Krambeer1 1Medical Center Ophthalmology Associates, 2University of Texas Health and Science Center at San Antonio, San Antonio, TX, USA Background: One limitation of...
Guardado en:
Autores principales: | Singer MA, Jansen ME, Tyler L, Woods P, Ansari F, Jain U, Singer J, Bell D, Krambeer C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a066b46ff9544836b4801c15b2768093 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska B, et al.
Publicado: (2017) -
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
por: Wallsh J, et al.
Publicado: (2016) -
Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017) -
Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh J, et al.
Publicado: (2020) -
Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
por: Michalska-Małecka K, et al.
Publicado: (2016)